» Articles » PMID: 35665211

A Preliminary Study of Peripheral T-cell Subsets in Porokeratosis Patients with or Variants

Overview
Journal Skin Health Dis
Specialty Dermatology
Date 2022 Jun 6
PMID 35665211
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Porokeratosis (PK) is considered a skin-specific autoinflammatory keratinization disease. Intriguingly, four causative genes of PK are in turn arranged in mevalonate pathway, with variants being the commonest followed by variants in a cohort of Chinese patients. Evidence indicates that mevalonate metabolites induce trained immunity in human monocytes and regulate T cells at multiple levels. Of note, γδT cells are dually regulated by intracellular and extracellular mevalonate metabolism.

Aims: To identify the possible differences in T-cell between or variants from PK patients.

Materials & Methods: Targeted exome sequencing and exonic CNV screening were performed in 26 patients with PK. Sanger sequencing was used to validate all identified variants. Among them, 22 patients were identified with or variants. PBMCs from 22 PK patients and 27 normal controls (NCs) were analysed by flow cytometry for the frequencies of T cells subsets, including IFN-γ-, and TNF-α-producing T cells.

Results: There were 14 mutations identified in the 26 PK patients, including 6 novel mutations (: c.118_226+1337dup, c.388_392delGATATinsC, c.613A>T, c.768G>C, and : c.250C>T, c.988T>G). In contrast to NCs, significantly decreased frequencies of CD8 and Vγ9Vδ2 T cells were observed in the PK patients with variants. Moreover, it was found that dysregulated secretion of pro-inflammatory cytokines by T cells in both PK patients with and variants.

Conclusions: Our findings enriched the Human Gene Mutation Databases and showed probable differences in peripheral T cells subsets between PK patients and controls.

Citing Articles

Establishment of a Mouse Model for Porokeratosis Due to Mevalonate Diphosphate Decarboxylase Deficiency.

Peng K, Wong W, Zhang Q, La Y, Tian Z, Sun R Skin Res Technol. 2024; 30(9):e70076.

PMID: 39323215 PMC: 11424814. DOI: 10.1111/srt.70076.


MVD Variants Identified in a Rare Clinical Variant of Porokeratosis: A Case Report of Disseminated Superficial Porokeratosis (DSP) in a Chinese Patient.

Yu T, Yin Y, Shu C, Yuan C Clin Cosmet Investig Dermatol. 2024; 17:1783-1787.

PMID: 39132030 PMC: 11313490. DOI: 10.2147/CCID.S473076.


Diseases categorized as autoinflammatory keratinization diseases (AiKDs), and their pathologies and treatments.

Akiyama M Nagoya J Med Sci. 2024; 86(1):1-15.

PMID: 38505726 PMC: 10945231. DOI: 10.18999/nagjms.86.1.1.


Two Novel and Three Recurrent Mutations in the Mevalonate Pathway Genes in Chinese Patients with Porokeratosis.

Wang X, Ouyang X, Zhang D, Zhu Y, Wu L, Xiao Z Clin Cosmet Investig Dermatol. 2024; 17:191-197.

PMID: 38283795 PMC: 10822103. DOI: 10.2147/CCID.S444985.


A preliminary study of peripheral T-cell subsets in porokeratosis patients with or variants.

Tao L, Huang Y, Yan K, Li C, Shen L, Zhang Z Skin Health Dis. 2022; 2(1):e82.

PMID: 35665211 PMC: 9060116. DOI: 10.1002/ski2.82.

References
1.
Szekanecz Z, McInnes I, Schett G, Szamosi S, Benko S, Szucs G . Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nat Rev Rheumatol. 2021; 17(10):585-595. DOI: 10.1038/s41584-021-00652-9. View

2.
Zhang Z, Li C, Wu F, Ma R, Luan J, Yang F . Genomic variations of the mevalonate pathway in porokeratosis. Elife. 2015; 4:e06322. PMC: 4511816. DOI: 10.7554/eLife.06322. View

3.
Boehncke W, Brembilla N . Autoreactive T-Lymphocytes in Inflammatory Skin Diseases. Front Immunol. 2019; 10:1198. PMC: 6549194. DOI: 10.3389/fimmu.2019.01198. View

4.
Kubo A, Sasaki T, Suzuki H, Shiohama A, Aoki S, Sato S . Clonal Expansion of Second-Hit Cells with Somatic Recombinations or C>T Transitions Form Porokeratosis in MVD or MVK Mutant Heterozygotes. J Invest Dermatol. 2019; 139(12):2458-2466.e9. DOI: 10.1016/j.jid.2019.05.020. View

5.
Tao L, Huang Y, Yan K, Li C, Shen L, Zhang Z . A preliminary study of peripheral T-cell subsets in porokeratosis patients with or variants. Skin Health Dis. 2022; 2(1):e82. PMC: 9060116. DOI: 10.1002/ski2.82. View